NEWAMSTERDAM PHARMA COMPANY

Ticker: NAMS CUSIP: N62509109 Class: Stock

Cormorant Asset Management, LP's Holding History (CIK: 0001583977)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 1,000,000 Value ($000) $35,080 Avg Close $36.39 Range $28.19 - $42.00
Q3 2025
Shares 2,175,000 Value ($000) $61,857 Avg Close $23.97 Range $17.97 - $28.91
Q2 2025
Shares 2,175,000 Value ($000) $39,389 Avg Close $18.24 Range $14.06 - $22.25
Q1 2025
Shares 2,825,000 Value ($000) $57,828 Avg Close $22.23 Range $17.18 - $26.80
Q4 2024
Shares 3,250,000 Value ($000) $83,525 Avg Close $21.24 Range $15.51 - $27.29
Q3 2024
Shares 2,470,000 Value ($000) $41,002 Avg Close $17.30 Range $15.19 - $21.48
Q2 2024
Shares 2,300,000 Value ($000) $44,183 Avg Close $20.06 Range $16.62 - $24.79
Q1 2024
Shares 1,500,000 Value ($000) $35,475 Avg Close $20.30 Range $11.18 - $26.35